Pharma Journalist -

AstraZeneca and its haematology research and development centre of excellence, Acerta Pharma, announced that the US Food and Drug Administration (FDA) has granted accelerated approval…
Read More...

Medicure International has acquired an exclusive license to sell and market PREXXARTAN (valsartan) oral solution in the United States and its territories from Carmel Biosciences, Inc.…
Read More...

MilliporeSigma today announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics…
Read More...

Impel NeuroPharma announced that the first patient was dosed in the recently-initiated Phase 1 clinical trial of INP104 for acute migraine headache. INP104 is a novel dihydroergotamine…
Read More...

As the North American biotech and pharmaceutical industry continues to reflect imminent growth, SMi Group has brought a portfolio of four significant pharmaceutical conferences to the…
Read More...

The 8th in its series, Pharmaceutical Microbiology East Coast, will debut in New Jersey, November 13- 14, 2017. With only three weeks remaining, both the pharmaceutical and specialty…
Read More...

Paediatric Clinical Trials 2018: Exploring the complexities of paediatric drug formulation to help determine clinical endpoints SMi is pleased to present the return of their 12th…
Read More...

SMi Group is proud to announce the return of Europe’s only Parallel Trade event conference, returning to Central London on 6th& 7th February 2018. The meeting will gather 90+ senior…
Read More...

Novartis announced that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender offer for 100% of the…
Read More...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Glycotope GmbH (hereafter, Glycotope) have signed an option agreement for future strategic collaboration and licensing to…
Read More...